<?xml version="1.0" encoding="UTF-8"?>
<ref id="B90-pharmaceuticals-12-00101">
 <label>90.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tong</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Bukreyeva</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Koma</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Manning</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Kalkeri</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kwong</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Paessler</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>149</volume>
  <fpage>34</fpage>
  <lpage>40</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.11.004</pub-id>
  <?supplied-pmid 29126899?>
  <pub-id pub-id-type="pmid">29126899</pub-id>
 </element-citation>
</ref>
